{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:04:28Z","timestamp":1790283868605,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":31,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010903","name":"Key Programme","doi-asserted-by":"publisher","award":["20232BBG70025"],"award-info":[{"award-number":["20232BBG70025"]}],"id":[{"id":"10.13039\/501100010903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2020-PT320-004"],"award-info":[{"award-number":["2020-PT320-004"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.prro.2026.07.007","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T16:09:29Z","timestamp":1787328569000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Overlap-Adapted Subvolume Prescription to Reduce Temporal Lobe Injury Risk in T4 Nasopharyngeal Carcinoma: A Prospective Cohort Study With a Contemporaneous Comparator"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-3281-9961","authenticated-orcid":false,"given":"Huadong","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzheng","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiying","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghui","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianzhu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4366-3851","authenticated-orcid":false,"given":"Xiaochang","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0389-7576","authenticated-orcid":false,"given":"Jingao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2026.07.007_bib0001","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","article-title":"Nasopharyngeal carcinoma","volume":"394","author":"Chen","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.prro.2026.07.007_bib0002","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S0140-6736(15)00055-0","article-title":"Nasopharyngeal carcinoma","volume":"387","author":"Chua","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.prro.2026.07.007_bib0003","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.radonc.2012.08.013","article-title":"A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma","volume":"104","author":"Peng","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2026.07.007_bib0004","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1470-2045(11)70303-5","article-title":"Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): A phase 2 multi-institutional trial","volume":"13","author":"Lee","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2026.07.007_bib0005","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.radonc.2014.02.003","article-title":"Evolution of treatment for nasopharyngeal cancer\u2013success and setback in the intensity-modulated radiotherapy era","volume":"110","author":"Lee","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2026.07.007_bib0006","article-title":"Radiation-induced temporal lobe injury for nasopharyngeal carcinoma: A comparison of intensity-modulated radiotherapy and conventional two-dimensional radiotherapy","volume":"8","author":"Zhou","year":"2013","journal-title":"PLOS One"},{"key":"10.1016\/j.prro.2026.07.007_bib0007","article-title":"LASSO-based NTCP model for radiation-induced temporal lobe injury developing after intensity-modulated radiotherapy of nasopharyngeal carcinoma","volume":"6","author":"Kong","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.prro.2026.07.007_bib0008","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ijrobp.2019.06.2540","article-title":"International guideline on dose prioritization and acceptance criteria in radiation therapy planning for nasopharyngeal carcinoma","volume":"105","author":"Lee","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2026.07.007_bib0009","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1200\/JCO.2008.19.9109","article-title":"Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: Radiation therapy oncology group phase II trial 0225","volume":"27","author":"Lee","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2026.07.007_bib0010","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/pro6.1219","article-title":"Precision radiotherapy for nasopharyngeal carcinoma","volume":"8","author":"Zhang","year":"2024","journal-title":"Precis Radiat Oncol"},{"key":"10.1016\/j.prro.2026.07.007_bib0011","first-page":"93","article-title":"The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.prro.2026.07.007_bib0012","series-title":"NCCN clinical practice guidelines in oncology: Head and neck cancers. Version 1","year":"2018"},{"key":"10.1016\/j.prro.2026.07.007_bib0013","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1056\/NEJMoa1905287","article-title":"Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma","volume":"381","author":"Zhang","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prro.2026.07.007_bib0014","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejca.2016.12.039","article-title":"Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial","volume":"75","author":"Cao","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.prro.2026.07.007_bib0015","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S1470-2045(16)30410-7","article-title":"Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase 3, multicentre, randomised controlled trial","volume":"17","author":"Sun","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2026.07.007_bib0016","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1093\/jnci\/djr432","article-title":"Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: Phase III randomized trial","volume":"103","author":"Chen","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.prro.2026.07.007_bib0017","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa1701717","article-title":"Analysis of plasma Epstein\u2013Barr virus DNA to screen for nasopharyngeal cancer","volume":"377","author":"Chan","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prro.2026.07.007_bib0018","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/annonc\/mdu117","article-title":"Plasma Epstein\u2013Barr viral DNA load at midpoint of radiotherapy course predicts outcome in advanced-stage nasopharyngeal carcinoma","volume":"25","author":"Leung","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.prro.2026.07.007_bib0019","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/pro6.1123","article-title":"Guidelines for radiotherapy of nasopharyngeal carcinoma","volume":"5","author":"Wang","year":"2021","journal-title":"Precis Radiat Oncol"},{"key":"10.1016\/j.prro.2026.07.007_bib0020","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1148\/radiology.213.3.r99dc07800","article-title":"Late radiation injury to the temporal lobes: Morphologic evaluation at MR imaging","volume":"213","author":"Chan","year":"1999","journal-title":"Radiology"},{"key":"10.1016\/j.prro.2026.07.007_bib0021","series-title":"Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0","year":"2017"},{"key":"10.1016\/j.prro.2026.07.007_bib0022","first-page":"541","article-title":"Chinese expert consensus on the diagnosis and management of radiation-induced brain injury","volume":"18","year":"2019","journal-title":"Chin J Neuromed"},{"key":"10.1016\/j.prro.2026.07.007_bib0023","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"10.1016\/j.prro.2026.07.007_bib0024","first-page":"1","article-title":"Prescribing, Recording, and Reporting Photon-Beam Intensity-Modulated Radiation Therapy (IMRT): Contents","volume":"10","year":"2010","journal-title":"J ICRU"},{"issue":"suppl","key":"10.1016\/j.prro.2026.07.007_bib0025","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.ijrobp.2009.02.091","article-title":"Radiation dose\u2013volume effects in the brain","volume":"76","author":"Lawrence","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2026.07.007_bib0026","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1186\/1471-2407-13-397","article-title":"Radiation-induced temporal lobe injury after intensity modulated radiotherapy in nasopharyngeal carcinoma patients: A dose-volume-outcome analysis","volume":"13","author":"Sun","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prro.2026.07.007_bib0027","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1148\/radiol.14141721","article-title":"Normal tissue complication probability model for radiation-induced temporal lobe injury after intensity-modulated radiation therapy for nasopharyngeal carcinoma","volume":"276","author":"Zeng","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.prro.2026.07.007_bib0028","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1748-717X-8-17","article-title":"Analysis of dosimetric factors associated with temporal lobe necrosis (TLN) in patients with nasopharyngeal carcinoma (NPC) after intensity modulated radiotherapy","volume":"8","author":"Su","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.prro.2026.07.007_bib0029","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13014-019-1229-9","article-title":"Dosimetric predictors of temporal lobe injury after intensity-modulated radiotherapy for T4 nasopharyngeal carcinoma: A competing risk study","volume":"14","author":"Huang","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.prro.2026.07.007_bib0030","doi-asserted-by":"crossref","first-page":"5773","DOI":"10.3390\/cancers14235773","article-title":"Current radiotherapy considerations for nasopharyngeal carcinoma","volume":"14","author":"Ng","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.prro.2026.07.007_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110258","article-title":"Dosimetric parameters predict radiation-induced temporal lobe necrosis in nasopharyngeal carcinoma patients: A systematic review and meta-analysis","volume":"195","author":"Dong","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2026.07.007_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110154","article-title":"The individualized delineation of clinical target volume for primary nasopharyngeal carcinoma based on invasion risk of substructures: A prospective, real-world study with a large population","volume":"194","author":"Wang","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2026.07.007_bib0033","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1118\/1.2818738","article-title":"Volumetric modulated arc therapy: IMRT in a single gantry arc","volume":"35","author":"Otto","year":"2008","journal-title":"Med Phys"},{"key":"10.1016\/j.prro.2026.07.007_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101324","article-title":"Local control and failure patterns after intensity modulated radiotherapy with reduced target volume delineation after induction chemotherapy for patients with T4 nasopharyngeal carcinoma","volume":"16","author":"Kong","year":"2022","journal-title":"Transl Oncol"},{"key":"10.1016\/j.prro.2026.07.007_bib0035","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2214\/ajr.175.2.1750431","article-title":"Radiation-induced temporal lobe changes","volume":"175","author":"Chong","year":"2000","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.prro.2026.07.007_bib0036","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/jmri.23788","article-title":"1H-MR spectroscopy and diffusion tensor imaging of normal-appearing temporal white matter in patients with nasopharyngeal carcinoma after irradiation: Initial experience","volume":"37","author":"Xiong","year":"2013","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.prro.2026.07.007_bib0037","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13014-020-01560-0","article-title":"Radiation induced temporal lobe necrosis in nasopharyngeal cancer patients after radical external beam radiotherapy","volume":"15","author":"Wu","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.prro.2026.07.007_bib0038","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1038\/bjc.2014.243","article-title":"Comparison of radiological and clinical features of temporal lobe necrosis in nasopharyngeal carcinoma patients treated with 2D radiotherapy or intensity-modulated radiotherapy","volume":"110","author":"Mao","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.prro.2026.07.007_bib0039","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13014-024-02400-1","article-title":"Evolution of radiation-induced temporal lobe injury after intensity-modulated radiation therapy in nasopharyngeal carcinoma: A large cohort retrospective study","volume":"19","author":"Hou","year":"2024","journal-title":"Radiat Oncol"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850026002602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850026002602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:39:59Z","timestamp":1790282399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850026002602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":39,"alternative-id":["S1879850026002602"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2026.07.007","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overlap-Adapted Subvolume Prescription to Reduce Temporal Lobe Injury Risk in T4 Nasopharyngeal Carcinoma: A Prospective Cohort Study With a Contemporaneous Comparator","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2026.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}]}}